# Comparison of Remimazolam and Dexmedetomidine for Intraoperative Sedation

> **NCT05447507** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 104 (actual)

## Conditions studied

- Orthopedic Disorder

## Interventions

- **DRUG:** Remimazolam
- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT05447507
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-08
- **Primary completion:** 2022-10-26
- **Final completion:** 2022-10-26
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2022-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05447507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05447507, "Comparison of Remimazolam and Dexmedetomidine for Intraoperative Sedation". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05447507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*